Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study.

Q3 Medicine

Journal of Immunotherapy and Precision Oncology Pub Date : 2022-02-01 DOI:10.36401/JIPO-21-20

Kyaw Z Thein, Siqing Fu, Filip Janku, Apostolia M Tsimberidou, Sarina A Piha-Paul, Daniel D Karp, Jatin Shah, Denái R Milton, Jing Gong, Selma Sulovic, Lacey McQuinn, Bettzy A Stephen, Rivka R Colen, Brett W Carter, Funda Meric-Bernstam, Aung Naing

引用次数: 1

Abstract

with carboplatin and pemetrexed with advanced

查看原文本刊更多论文

Selinexor联合卡铂和培美曲塞治疗晚期或转移性实体瘤:一项开放标签、单中心、多组1b期研究的结果

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Immunotherapy and Precision Oncology Medicine-Oncology

CiteScore

2.40

自引率

0.00%

发文量